Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
£20,780 per year, and includes a 3-month fusion engineering CDT training programme as part of the 2025 Cohort. This project is co-supervised by Dr Chris Hardie from UKAEA. The UoB Materials for eXtremes
-
(FSTM) at the University of Luxembourg contributes multidisciplinary expertise in the fields of Mathematics, Physics, Engineering, Computer Science, Life Sciences and Medicine. Through its dual mission
-
PhD Position in Hydrogen/Deuterium Exchange Mass Spectrometry to Study the Regulation of Lipoprot...
environment in proteomics, protein chemistry, biomolecular mass spectrometry, and computational proteomics. Qualifications We are looking for a highly motivated and enthusiastic candidate with excellent
-
this initiative, 15 early-stage doctoral candidates (DCs) will be trained through a comprehensive, interdisciplinary program spanning material science, device physics, computer architecture, hardware prototyping
-
this initiative, 15 early-stage doctoral candidates (DCs) will be trained through a comprehensive, interdisciplinary program spanning material science, device physics, computer architecture, hardware prototyping
-
this initiative, 15 early-stage doctoral candidates (DCs) will be trained through a comprehensive, interdisciplinary program spanning material science, device physics, computer architecture, hardware prototyping
-
(Associate Professor) Ashraf Uz Zaman (zaman@chalmers.se) and Prof. Jian Yang (jian.yang@chalmers.se) Who we are looking for Applicants should have, or expect to receive, a Master of Science degree
-
two other researchers dedicated to this project. The project is in close collaboration between the Centre for Textile Science and Engineering (Prof. Lode Daelemans) and the Mechanics of Materials and
-
£20,780 per year, and includes a 3-month fusion engineering CDT training programme as part of the 2026 Cohort. This project is co-supervised by Dr Chris Hardie from UKAEA. The UoB Materials for eXtremes
-
treatment and improved clinical outcomes. The supervisory team of Dr. Paul Facey, Dr. Claire Morgan and Prof. Dean Harris, bringing expertise in cancer genomics, microbiology, and clinical translation